StockWatch
·

InMed Pharmaceuticals Inc. Q2 FY26 Results

INMQ2 FY26 Results
MetricValue ($ M)Q1 FY26Q2 FY25
Revenue0.8226.8%26.1%
Total Income0.8226.8%26.1%
Expenditure2.850.0%22.8%
PBT-2.0317.3%21.3%
Net Profit-2.0317.3%21.3%
OPM
NPM
EPS-0.5115.9%86.0%
View full financials

Informational and educational content only. Not investment advice.